Neurogene Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Neurogene Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q2 2024.
  • Neurogene Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.31M, a 503% increase year-over-year.
  • Neurogene Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $4.1M.
  • Neurogene Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.42M, a 13.3% increase from 2022.
  • Neurogene Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.25M, a 89.2% decline from 2021.
  • Neurogene Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.6M, a 106% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $4.1M $2.31M +$1.93M +503% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $2.17M $1.05M +$752K +257% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $1.42M $569K +$6.11M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 -$4.69M $172K -$1.86M -91.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$2.83M $384K -$1.93M -83.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$901K $293K -$2.15M -88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $1.25M -$5.54M -$8.55M -284% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 $9.8M $2.03M -$1.18M -36.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $11M $2.31M -$606K -20.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $11.6M $2.45M +$26K +1.07% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $11.6M $3.01M +$780K +35% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 $10.8M $3.21M +$1.52M +90.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $9.26M $2.92M +$1.9M +186% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $7.36M $2.42M +$1.74M +254% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $5.62M $2.23M +$1.59M +246% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $4.04M $1.69M -$3.46M -67.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $7.5M $1.02M +$234K +29.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $7.27M $683K -$417K -37.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $7.68M $644K +$244K +61% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 $7.44M $5.15M +$3.65M +243% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $3.79M $788K -$712K -47.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $4.5M $1.1M -$200K -15.4% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $4.7M $400K -$500K -55.6% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-07
Q3 2018 $5.2M $1.5M +$300K +25% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $4.9M $1.5M +$400K +36.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $4.5M $1.3M +$700K +117% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $3.8M $900K +$333K +58.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 $3.47M $1.2M +$700K +140% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $2.77M $1.1M +$600K +120% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $2.17M $600K +$167K +38.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $2M $567K +$212K +59.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 $1.79M $500K +$76K +17.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $1.71M $500K +$45K +9.89% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $1.67M $433K +$167K +62.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $1.5M $355K +$87K +32.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 $1.41M $424K +$191K +82% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $1.22M $455K +$240K +112% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $982K $266K +$128K +92.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $854K $268K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 $233K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $215K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $138K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.